Bergen, Norway, 23 January 2024: Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), has appointed Renete Kaarvik as Chief Financial Officer effective 1 Mai, 2024.

Kaarvik joins Lifecare from the position as Global Finance Officer at Grieg Seafood ASA, a position she has held for close to six years. 

Lifecares main operational focus is to establish automated manufacturing by end of Q2 2024, including preparations for market launch in the veterinary market. As part of the company’s growth strategy, the Board of Directors wish to strengthen the company’s executive management with focus on financial management and strategy. In addition to the expectation of increased commercial activities that will bring the company into a new phase, the Board of Directors wish to explore the potential of uplisting Lifecare to Oslo Børs Main Market. 

“We are very pleased to welcome Renete to Lifecare. She brings valuable competence and experience to the Lifecare Group. During the last year we have repeatedly highlighted the importance of establishing solid product and manufacturing fundaments, based on proven research and systemic quality management. With this appointment we establish the CFO position to further strengthen the Group capacities. We are confident that Renete will play an important role on forming the Groups financial strategies aligned with our growth strategy and strengthen the fundament for both the product and Group organization to the best of the shareholders’ interests", says Lifecare CEO Joacim Holter. 

Kaarvik graduated in 2004 from Macquarie University, Sydney, Australia, with a Master of Applied Finance. She also holds a Master of Science in Business from Bodø Graduate School of Business (1998). 

In addition to the aforementioned professional experience, Kaarvik has held Group Controller, Compliance Officer and Finance Manager positions in Mowi ASA and Marine Farms ASA, as well as Manager and Senior Associate positions in Ernst & Young and PricewaterhouseCoopers within Transaction and Business Advisory Services and Auditing. Furthermore, Kaarvik’s professional experience also include Senior Associate, Project Manager and Associate positions within private equity at HitecVision Private Equity and Arthur Andersen (Portugal). 

About us
Lifecare AS is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the next generation of Continuous Glucose Monitoring (“CGM”) systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors (“NTR”) on the sensor body for read-out of pressure variations. Lifecare’s sensor technology is referred to as “Sencell” and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body.

Contacts
For further information, please contact:

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs, asle.wingsternes@lifecare.no, +47 41 61 42 52

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 19 no. 3. The information was submitted for publication at 2024-01-23 08:00 CET.

Attachments
Stock Exchange Notification – Lifecare – Appointment of CFO

© Modular Finance, source Nordic Press Releases